Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1CNS 1

Conditions

Wilms Tumor 1Sarcoma, Ewing 1Retinoblastoma 1Neuroblastoma 1Glioma 1

Interventions

Granulocyte Colony-Stimulating Factor 5Filgrastim 5Thiotepa 3Cyclophosphamide 3sargramostim 2Topotecan 2Melphalan 2Ifosfamide 2Etoposide 2Carboplatin 2Busulfan 2racotumomab 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1omburtamab I-131 1entinostat 1cixutumumab 1atezolizumab 1alvocidib 1Thrombopoietin 1Thalidomide 1Stem Cell Transplantation 1Sirolimus 1Simvastatin 1Radiotherapy, Intensity-Modulated 1Platinum 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Mesna 1Itraconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Wilms Tumor × racotumomab × Other solid neoplasm × Clear all
NCT01598454 2015-07-29

Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides

Laboratorio Elea Phoenix S.A.

Phase 1 Completed
15 enrolled
CNSGenitourinaryOther solid neoplasmSarcoma

Glioma, Wilms Tumor, Neuroblastoma, Retinoblastoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡